Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial [0.03%]
挽救性转移灶导向治疗与选择性淋巴结治疗寡病程前列腺癌患者的健康相关生活质量结局：PEACE V-STORM二期开放标签随机试验的二次分析结果
Thomas Zilli,Shankar Siva,Sigmund Brabrand et al.
Thomas Zilli et al.
For prostate cancer patients with metachronous nodal oligorecurrences detected by positron emission tomography, the randomized phase 2 PEACE V-STORM trial (NCT03569241) demonstrated that, compared with metastasis-directed therapy (MDT), ele...
Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium [0.03%]
转移性非透明细胞肾癌患者接受当代或传统一线治疗的预后：国际转移性肾细胞癌数据库联盟的结果分析
Kosuke Takemura,Jeffrey Graham,David Maj et al.
Kosuke Takemura et al.
Background and objective: Real-world evidence on the effectiveness of first-line immuno-oncology (IO)-based combinations or cabozantinib (CABO) over traditional targeted therapies in metastatic non-clear cell renal cell c...
Reply to Matthias May, Ingmar Wolff, Sabine Brookman-May, and Maximilian Burger's Letter to the Editor re: Paramananthan Mariappan, Jasmin Hart-Brooke, Rebecca Sparks, Tanya Lord-McKenzie. Bladder EpiCheck Triggered Photodynamic Diagnosis Biopsies Detect High-grade Bladder Cancer Recurrences Missed by White Light Cystoscopy. Eur Urol Oncol. In [0.03%]
有关Paramananthan Mariappan，Jasmin Hart-Brooke，Rebecca Sparks，Tanya Lord-McKenzie的Letter to the Editor回复：Bladder EpiCheck激发光动力学诊断活检可检测出白光膀胱镜遗漏的高级别复发性膀胱癌《欧洲泌尿肿瘤学会杂志》发表
Paramananthan Mariappan,Jasmin Hart-Brooke,Rebecca Sparks et al.
Paramananthan Mariappan et al.
Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research Study [0.03%]
前列腺癌患者的家庭护理经验：来自欧洲男性肿瘤联合会的研究证据
Lionne D F Venderbos,Sebastiaan Remmers,André Deschamps et al.
Lionne D F Venderbos et al.
Background and objective: Partners of prostate cancer (PCa) patients may play an important role in the care process. Therefore, Europa Uomo initiated the Europa Uomo Prostate cancer Partners in Europe Research (EU-ProPER)...
Best Practice in Preoperative Surgical Planning for Robotic-assisted Radical Prostatectomy: A European Consensus Statement [0.03%]
机器人辅助根治性前列腺切除术的术前外科手术规划共识声明的最佳实践
Elizabeth Day,Anders Bjartell,Ashwin Sridhar et al.
Elizabeth Day et al.
Background and objective: The surgical plan in robotic-assisted radical prostatectomy (RARP) aims to achieve optimal perioperative, oncological, and functional outcomes by recommending the extent of resection and use of f...
Effects of Causal and Noncausal Components of Screening on Prostate Cancer Mortality: A Mediation Analysis from the Dutch, Finnish, and Swedish Centers of the European Randomized Study of Screening for Prostate Cancer [0.03%]
欧洲前列腺癌筛查试验荷兰、芬兰和瑞典中心筛查因果和非因果成分对前列腺癌死亡率影响的中介分析
Sebastiaan Remmers,Kirsi Talala,Monique J Roobol et al.
Sebastiaan Remmers et al.
Background and objective: The European Randomized Study of Screening for Prostate Cancer (ERSPC) has shown that prostate-specific antigen (PSA)-based screening reduces prostate cancer (PCa)-specific mortality (PCSM). Howe...
Reply to Philipp Korn, Maximillian Pallauf, and Nirmish Singla's Letter to the Editor re: Michele Nicolazzini, Matteo Berra, Paolo De Angelis, et al. New TNM Staging System Predicts Progression of Small Renal Masses Under Active Surveillance: A Retrospective Analysis of a Single-center Prospective Series. Eur Urol Oncol. In press. https://doi.o [0.03%]
关于 Philipp Korn、Maximillian Pallauf 和 Nirmish Singla 来信的回复：Michele Nicolazzini、Matteo Berra、Paolo De Angelis 等人。新的 TNM 分期系统可预测主动监测下小肾病的发展：单中心前瞻性系列研究的回顾性分析
Michele Nicolazzini,Matteo Berra,Paolo De Angelis et al.
Michele Nicolazzini et al.
Stereotactic Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer: Final Results of a Phase 2b Trial [0.03%]
立体定向放射治疗未行全身治疗的寡转移性肾癌患者：Ⅱb期临床试验最终结果分析
Raquibul Hannan,Ryan Assadi,Alana Christie et al.
Raquibul Hannan et al.
Background and objective: Management of oligometastatic renal cell carcinoma (omRCC) remains undefined, especially in favorable- and intermediate-risk patients, in whom treatment de-escalation may reduce toxicity and pres...
Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer [0.03%]
AFU-GETUG-20三期随机试验结果：评估促性腺激素释放激素激动剂亮丙瑞林乙酸盐在高危局限性前列腺癌根治术后辅助治疗中的疗效
François Rozet,Alain Ruffion,Pablo Lemercier et al.
François Rozet et al.
Background and objective: Androgen-deprivation therapy survival benefits after radical prostatectomy (RP) in nonmetastatic high-risk prostate cancer (PCa) patients with an undetectable prostate-specific antigen (PSA) leve...
Re: Andrea Necchi, Félix Guerrero-Ramos, Paul L. Crispen, et al. Gemcitabine Intravesical System plus Cetrelimab or Cetrelimab Alone as Neoadjuvant Therapy in Patients with MIBC: Primary Analysis and Biomarker Results of SunRISe-4. J Clin Oncol. In press. https://doi.org/10.1200/JCO-25-02382 [0.03%]
内镜下肌内浸润性膀胱癌新辅助治疗：SunRISe-4研究的初步分析和生物标志物结果
Giuseppe Di Lorenzo,Carlo Buonerba
Giuseppe Di Lorenzo